Corporate Information And Statement Of Ifrs Compliance [Abstract]

GenSight Biologics S.A. - Filing #5982864

Concept	As at 2024-12-31	2024-01-01 to 2024-12-31	As at 2023-12-31
Corporate information and statement of IFRS compliance [abstract]
Name of reporting entity or other means of identification	—	GenSight Biologics	—
Legal form of entity	—	(société anonyme)	—
Country of incorporation	—	France	—
Address of entity's registered office	—	74, rue du Faubourg Saint-Antoine – 75012 Paris	—
Statement of IFRS compliance [text block]	—	2	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block]	—	—	—
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract]
Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items]
Current trade receivables	1,000 EUR	—	1,000 EUR
Current trade payables	6 357 EUR	—	5,634,000 EUR
Disclosure of material accounting policy information [text block]	—	Note 3:	—